• Bringing More Value with ScienceWe will bring value by enriching our product pipeline with redesigned FDA-approved drug products that meet unmet medical needs.

    Bringing More Value
    with Science

    We will bring value by enriching our product pipeline with redesigned
    FDA-approved drug products that meet unmet medical needs.

portrait indu

Indu Muni, Ph. D.
Founder and CEO

Prior to starting Romeg Therapeutics, Dr. Muni founded CutisPharma in 1998 and served as the Company's CEO until May 2015. Dr. Muni brings over 40 years of experience in the pharmaceutical industry, with a deep background in pharmacy and toxicology. Previously, Dr. Muni served as the CEO of DynaGen, Inc., a publicly-held biotechnology company. Prior to DynaGen, Dr. Muni served in numerous senior level positions in the pharmaceutical, chemical and toxicology testing industries including BioAssay Systems, Inc., Miles Laboratories, and JT Baker. Dr. Muni has a Ph.D. in Pharmaceutical Sciences from the University of Mississippi.

portrait gita

Gita Muni, M.S., M.T.
Cofounder and
Executive Vice President

Prior to co-founding Romeg Therapeutics, Gita Muni helped found Cutis Pharma in 1998 and served as V.P. of Administration until May 2015.  Prior to Cutis Pharma, she worked at DynaGen, Inc. helping to monitor clinical trials at various locations.  Additionally, she worked at the local hospitals as a medical technologist, (M.T.) Gita Muni holds a M.S. in pharmaceutical sciences from Bombay University, India, and she is also a registered medical technologist, (A.S.C.P.).

portrait naomi

Naomi Vishnupad, Ph. D.
Vice President
Technical Affairs

Dr. Vishnupad is an entrepreneurial scientific business executive with over 15 years of experience in inventing novel products and bringing new product technologies to the prescription and life sciences market.  She has served as the COO at Imaginative Research Associates, a dermatological product development company, for 14 years.  Previously, Dr. Vishnupad held positions at Wyeth Pharmaceuticals and Bristol-Myers Squibb.  She received a Ph.D. in Immunology from MCP-Hahnemann/Drexel University School of Medicine, a M.S. in Immunology from NYU, and a B.S. in Biology from Boston University.

Save

Save

Want to hear more about what is going on?

icon mail

icon phone